Rise Therapeutics LLC
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD (NCT07076290) | Rise Therapeutics LLC | 2026-09-01 |
| R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS) (NCT07646028) | Rise Therapeutics LLC | 2026-09-01 |
| R-2487 in Patients With Sjogren's Syndrome (SS) (NCT06297213) | Rise Therapeutics LLC | 2026-06-01 |
| R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors (NCT06398418) | Rise Therapeutics LLC | 2025-08-01 |
| R-5280 in Newly Diagnosed Patients With Type 1 Diabetes (NCT06057454) | Rise Therapeutics LLC | 2023-12-05 |
| R-2487 in Patients With Rheumatoid Arthritis (NCT05961592) | Rise Therapeutics LLC | 2023-10-19 |
| R-3750 in Patients With Mild to Moderate Ulcerative Colitis (NCT05666960) | Rise Therapeutics LLC | 2023-02-27 |
Track Rise Therapeutics LLC automatically
Every clearance here is in the API, with alerts when new ones post.